Scripsamerica Cost of Goods Sold 2013-2015 | SCRCQ

Scripsamerica cost of goods sold from 2013 to 2015. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Scripsamerica Annual Cost of Goods Sold
(Millions of US $)
2014 $3
2013 $0
2012 $3
Scripsamerica Quarterly Cost of Goods Sold
(Millions of US $)
2015-03-31 $2
2014-12-31
2014-09-30 $1
2014-03-31 $0
2013-12-31
2013-09-30 $0
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs. The Company is focused on pharmaceutical supply chain management services, from strategic sourcing to delivering niche generic pharmaceuticals to market. It delivers pharmaceutical products to a range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The Company's therapeutic categories include pain, arthritis, prenatal, urinary and hormonal replacement drugs. ScripsAmerica, Inc. is based in Tysons Corner, Virginia.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.424B 21.35
Becton Dickinson (BDX) United States $49.374B 12.23
Cardinal Health (CAH) United States $36.267B 18.99
Straumann Holding AG (SAUHY) Switzerland $21.415B 0.00
Labcorp (LH) United States $20.613B 16.72
Cooper (COO) United States $16.288B 21.60
West Pharmaceutical Services (WST) United States $15.136B 31.73
Align Technology (ALGN) United States $13.534B 26.87
Henry Schein (HSIC) United States $8.708B 14.94
Merit Medical Systems (MMSI) United States $5.766B 27.88
DENTSPLY SIRONA (XRAY) United States $3.288B 9.82
CONMED (CNMD) United States $1.847B 13.82
STAAR Surgical (STAA) United States $0.906B 0.00
Lifevantage (LFVN) United States $0.159B 16.38
Pro-Dex (PDEX) United States $0.141B 15.40